NCT07488221

Brief Summary

HIV testing uptake among male partners of pregnant women remains low. But the optimal way to engage the male partners is unknown. The antenatal setting, with nearly universal uptake of HIV testing for women, can serve as a way of reaching male partners. HIV self-testing (HIVST) is one approach to HIV testing that can be conducted out of health facility. HIVST is a rapid antibody test which can be performed by non-medical people and allows people to collect their own specimen, perform the test, and interpret the results in the privacy of their home or other preferred location. In this trial HIV-negative pregnant women who were attending antenatal care at Bwaila Hospital in Malawi will be randomized 1:1 to receive partner notification inviting their partners for clinic-based HIV testing (standard of care) or partner notification + HIV Self-test kit for partner testing at home (intervention).

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
200

participants targeted

Target at P50-P75 for not_applicable hiv-infections

Timeline
Completed

Started Oct 2019

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

October 8, 2019

Completed
1.9 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

August 17, 2021

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

August 17, 2021

Completed
4.6 years until next milestone

First Submitted

Initial submission to the registry

March 11, 2026

Completed
12 days until next milestone

First Posted

Study publicly available on registry

March 23, 2026

Completed
25 days until next milestone

Results Posted

Study results publicly available

April 17, 2026

Completed
Last Updated

April 17, 2026

Status Verified

March 1, 2026

Enrollment Period

1.9 years

First QC Date

March 11, 2026

Results QC Date

March 30, 2026

Last Update Submit

March 30, 2026

Conditions

Keywords

HIV self-testHIV testing uptakeHIV Testing in Male Partners

Outcome Measures

Primary Outcomes (1)

  • Proportion of Male Partners Who Reported to Clinic

    within 30 days of their female partner enrollment into the study

Secondary Outcomes (1)

  • Time Taken for Male Partners to Report to Clinic

    within 30 days from female partner enrollment into the study

Study Arms (2)

Partner Notification Slip only

ACTIVE COMPARATOR

Participants in this group receive standard of care (partner notification slip only)

Behavioral: Partner Notification Slip only

Partner Notification Slip plus HIV Self-test Kit

EXPERIMENTAL

Participants in this group receive the experimental intervention (Partner Notification Slip plus HIV Self-test Kit)

Other: Partner Notification Slip plus HIV Self-test kit

Interventions

Partner Notification Slip plus HIV Self-test kit

Partner Notification Slip plus HIV Self-test Kit

Partner Notification Slip only

Partner Notification Slip only

Eligibility Criteria

Age18 Years+
Sexfemale
Healthy VolunteersYes
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • HIV-negative pregnant woman
  • Must be available and willing to be contacted by phone within the next 30 days
  • Must be part of a heterosexual relationship for \>3 months
  • Must expects their male sexual partner to be able to come to clinic in the next 30 days

You may not qualify if:

  • unable to provide informed consent

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

UNC Project Malawi

Lilongwe, Malawi

Location

MeSH Terms

Conditions

HIV Infections

Condition Hierarchy (Ancestors)

Blood-Borne InfectionsCommunicable DiseasesInfectionsSexually Transmitted Diseases, ViralSexually Transmitted DiseasesLentivirus InfectionsRetroviridae InfectionsRNA Virus InfectionsVirus DiseasesGenital DiseasesUrogenital DiseasesImmunologic Deficiency SyndromesImmune System Diseases

Results Point of Contact

Title
Maganizo Chagomerana, PhD
Organization
University of North Carolina at Chapel Hill

Study Officials

  • Maganizo B Chagomerana, PhD

    University of North Carolina, Chapel Hill

    PRINCIPAL INVESTIGATOR

Publication Agreements

PI is Sponsor Employee
Yes

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
NONE
Purpose
HEALTH SERVICES RESEARCH
Intervention Model
PARALLEL
Model Details: HIV-negative pregnant women will be randomized 1:1 to receive partner notification clip inviting their partners for clinic-based HIV testing (standard of care ) or partner notification slip + HIV Self-test kit for partner testing at home (intervention).
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

March 11, 2026

First Posted

March 23, 2026

Study Start

October 8, 2019

Primary Completion

August 17, 2021

Study Completion

August 17, 2021

Last Updated

April 17, 2026

Results First Posted

April 17, 2026

Record last verified: 2026-03

Data Sharing

IPD Sharing
Will share

Deidentified individual data that supports the results will be shared beginning 6 to 12 months following publication provided the investigator who proposes to use the data has approval form an Institutional Review Board (IRB), Independent Ethics committee (IEC), or Research Ethics Board (REB), as applicable, and executes a data use/sharing agreement with UNC.

Shared Documents
STUDY PROTOCOL, ICF, ANALYTIC CODE
Time Frame
Beginning 6 and continuing for 12 months following publication
Access Criteria
Investigator has approved IRB, IEC, or REB and an executed data use/sharing agreement with UNC

Locations